This page shows the latest Sun Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.
Sun Pharmaceutical’s Ilumya (tildrakizumab) in recent years.
As well as Teva, India-domiciled drugmaker Sun Pharmaceutical has also been in talks with the DoJ to settle the allegations.
India’s largest drugmaker Sun Pharmaceutical has picked up its first FDA approval for a novel drug, getting the nod for plaque psoriasis therapy Ilumya. ... Ilumya isn’t entirely home-grown, as Sun Pharma licensed the interleukin-23 (IL-23) inhibitor
Will continue partnership on diabetes and inflammatory disorder projects. Merck &Co and India's Sun Pharmaceutical Industries have agreed to dissolve a joint venture set up in 2011 to develop and ... Sun acquired global rights to tildrakizumab (MK-3222)
Daiichi Sankyo has found a buyer for its $3.6bn holding in India's Sun Pharmaceutical almost immediately after putting the stake up for sale. ... The merger of Sun and Ranbaxy created the world's fifth largest speciality generic pharmaceutical company
Ranbaxy is the subject of $4bn takeover bid from fellow Indian firm Sun Pharmaceutical that would offer its current majority shareholder Daiichi Sankyo a partial exit.
More from news
Approximately 2 fully matching, plus 35 partially matching documents found.
India's Sun Pharmaceutical has partnered with Mitsubishi Tanabe Pharma to distribute and market 14 prescription drugs in Japan that Sun recently acquired from Novartis. ... No financial terms were disclosed. Genentech signed an exclusive licence [global
April also saw Sun Pharmaceutical Industries relieving Daiichi Sankyo (63.9% owner) of the troubled Ranbaxy Laboratories to create India's largest pharma company, leading in 13 speciality segments, with estimated ... is rumoured that a solution will be
Pfizer (Wyeth) Takeda / Teva Sun Pharmaceutical. Patent settlement. Infringement of Protonix patent. ... 39.5. BioLineRx / Jiangsu Chia-tai Tianqing Pharmaceutical (CTTQ)†. Collaboration and licence.
Top of the table is the patent settlement between Pfizer/ Takeda and Teva/ Sun Pharmaceutical for the launch of generic versions of Protonix (the proton pump inhibitor, pantoprazole) in 2007 ahead ... damages (Teva $1.6bn and Sun Pharma $550m); Pfizer
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...